Prospective evaluation of pulmonary function in cancer patients treated with total body irradiation, high-dose melphalan, and autologous hematopoietic stem cell transplantation.

[1]  G. Bonadonna,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Piantadosi.  Hazards of small clinical trials. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Pileri,et al.  GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION , 1989, The Lancet.

[4]  G. Bonadonna,et al.  High dose chemo-radiotherapy for sensitive tumors: is sequential better than concurrent drug delivery? , 1989, European journal of cancer & clinical oncology.

[5]  H. Balfour,et al.  A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. , 1989, The New England journal of medicine.

[6]  G. Bonadonna,et al.  Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo‐radiotherapy? , 1989, Hematological oncology.

[7]  R. Wittes,et al.  Autologous bone marrow transplantation. Current status and future directions. , 1989, Annals of internal medicine.

[8]  D. Schwartz,et al.  Risk factors for airflow obstruction in recipients of bone marrow transplants. , 1987, Annals of internal medicine.

[9]  F. Appelbaum,et al.  Interstitial pneumonitis following autologous bone marrow transplantation. , 1986, Transplantation.

[10]  A. Santoro,et al.  Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. , 1986, Annals of internal medicine.

[11]  J. Connors,et al.  MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. , 1985, Annals of internal medicine.

[12]  A. Santoro,et al.  Third-line salvage chemotherapy in Hodgkin's disease. , 1985, Seminars in oncology.

[13]  J. Fay,et al.  Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. , 1984, The New England journal of medicine.

[14]  A. Barrett,et al.  Lung function after bone marrow grafting. , 1983, International journal of radiation oncology, biology, physics.

[15]  N. Flournoy,et al.  Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. , 1982, Reviews of infectious diseases.

[16]  R. Comis,et al.  The pulmonary toxicity of antineoplastic agents. , 1982, Seminars in oncology.

[17]  C. Connolly.  Respiratory Medicine and Intensive Care for the House Officer , 1982 .

[18]  P. Dinakara,et al.  The effect of anemia on pulmonary diffusing capacity with derivation of a correction equation. , 2015, The American review of respiratory disease.

[19]  R. Forster,et al.  A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. , 1957, The Journal of clinical investigation.